abstract |
The invention provides an anti-CTLA4 antibody which inhibits the binding of CTLA4 to human B7,in particular,it inhibits binding of CTLA4 to human B7.1 and/or human B7.2. Specific antibodies are provided with specific variable region sequences as well as compositions comprising such antibodies for use in treating disease. |